The global autoimmune disease diagnostics market to grow at a CAGR of 6.39% during the period 2016-2020.
Global Autoimmune Disease Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
A trend contributing to market growth is the shift from monoplex to multiplex testing. The focus on multiplex testing is increasing, particularly in the area of in vitro diagnostics. Singleplex systems can analyze a single analyte from test samples for disease diagnosis. On the other hand, multiplexed assays can analyze samples by detecting multiple analytes from a single or multiple samples, offering a high-throughput solution. These multiplexed systems are cost-effective, require limited labor, and have increased efficiency and turnaround time in the delivery of results.
According to the report, a key growth driver is the discovery of novel biomarkers. Autoimmune diseases are of various types, with each individual exhibiting different symptoms if affected by at least two disease types. This makes it difficult for physicians to diagnose disease types. Biomarkers linked to autoimmune diseases are currently being discovered and studied, which has led to the development of biomarker-specific new diagnostic products. For instance, in 2013, researchers in the University of Cincinnati, US, identified various protein-based biomarkers associated with inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.
Further, the report states that one challenge that could restrict market growth is the lack of skilled lab technicians.